Current organ supply is only able to satisfy 15% of worldwide demand. According to American Transplant Foundation, 20 people in the US alone die every day from the lack of available organs for transplant. The problem will be exacerbated by increases in human longevity.
New Organs Biotech is a gene editing and genome engineering company working on increasing organ supply by using CRIPSR/Cas technology to develop safe and effective human transplantable organs, tissues and cells.
We are a diverse team of scientists and entrepreneurs focused on developing a solution to a problem that affects millions of people around the world